Staar Surgical price to book ratio STAA
Market value divided by the book value of the company's net assets, since 2011.
- Today, Oct 23, 2026
- 3.1×
- 10-year median
- 10.5×
- Against its 10-year history
- 11th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 1.8× to 41.3×
- Peer median
- 3.2×
Staar Surgical's price to book ratio is 3.1× as of Oct 23, 2026.
That is below its ten-year median of 10.5×, lower than on 89% of days in the last ten years.
Over that time it ranged from 1.8× in Feb 2025 to 41.3× in Sep 2018.
The median for 10 medical instruments and supplies stocks of a similar size is 3.2×.
Price to book ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 3.1× | 2.3× | 4.6× |
| 2025 | 3.3× | 1.8× | 4.2× |
| 2024 | 2.8× | 2.8× | 6.3× |
| 2023 | 4.0× | 4.0× | 11.7× |
| 2022 | 7.3× | 7.3× | 17.9× |
| 2021 | 17.4× | 17.1× | 33.5× |
| 2020 | 19.6× | 7.3× | 20.3× |
| 2019 | 10.9× | 7.5× | 13.6× |
| 2018 | 10.7× | 10.2× | 41.3× |
| 2017 | 15.7× | 10.0× | 17.2× |
| 2016 | 11.7× | 5.6× | 12.3× |
| 2015 | 7.2× | 5.7× | 11.4× |
| 2014 | 8.7× | 8.3× | 18.7× |
| 2013 | 15.9× | 5.9× | 15.9× |
| 2012 | 6.5× | 5.8× | 14.5× |
| 2011 | 13.3× | 7.4× | 14.4× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Staar Surgical's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| STAAStaar Surgical | 3.1× |
| IRMDIradimed | 10.8× |
| BVSBioventus | 5.5× |
| CDRECadre | 3.7× |
| EYENational Vision | 1.6× |
| MOVMovado | 1.4× |
| LMATLemaitre Vascular | 4.6× |
| INSPInspire Medical Systems | 2.5× |
| MDXGMimedx | 2.6× |
| UFPTUFP Technologies | 5.0× |
| TCMDTactile Systems Technology | 2.4× |
| Peer median | 3.2× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Staar Surgical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.